Watchlist Price Alert

SpringWorks Therapeutics ... (SWTX)

NASDAQ: SWTX · Real-Time Price · USD

46.87

0.00 (0.00%)

At close: Jun 17, 2025, 12:20 PM

SpringWorks Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-258.13M	-325.1M	-277.42M	-173.91M	-45.57M	-58.31M	-17.81M	-4.64M
Depreciation & Amortization	3.47M	1.67M	765K	490K	349K	192K	17K	3.18K
Stock-Based Compensation	109.14M	94.53M	72.97M	38.44M	10.03M	3.11M	1.07M	n/a
Other Working Capital	4.95M	8.65M	33.94M	3.04M	2.65M	3.07M	1.53M	100K
Other Non-Cash Items	7.79M	6.69M	4.02M	993K	1.05M	2.61M	612.33K	1.74M
Deferred Income Tax	n/a	n/a	n/a	988K	605K	n/a	n/a	n/a
Change in Working Capital	-37.86M	-583K	38.1M	5.12M	1.35M	4.95M	2.02M	383K
Operating Cash Flow	-175.6M	-222.79M	-161.56M	-127.88M	-32.19M	-47.44M	-14.71M	-2.24M
Capital Expenditures	-4.45M	-7.38M	-10.2M	-2.02M	-642K	-670K	-293K	-44K
Cash Acquisitions	n/a	-2.8M	-4.2M	2.02M	-3.5M	-3.59M	n/a	n/a
Purchase of Investments	-285.1M	-575.72M	-481.05M	-305.42M	-442.69M	-3.59M	n/a	n/a
Sales Maturities Of Investments	378.58M	620.66M	279.85M	391.03M	28M	3.59M	n/a	n/a
Other Investing Acitivies	-24.48M	n/a	-205.4M	-2.02M	-418.19M	-3.59K	n/a	n/a
Investing Cash Flow	64.55M	34.75M	-215.6M	83.59M	-418.83M	-4.26M	-293K	-44K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	-8.44M	-2.8M	-1.34M	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	4.76M	139K	1.98M	1.16M	893K	21K	n/a	12.55M
Financial Cash Flow	4.76M	296.64M	340.7M	1.16M	270.49M	333.71M	50.38M	12.55M
Net Cash Flow	-106.29M	108.6M	-36.46M	-43.13M	-180.54M	282M	35.38M	10.27M
Free Cash Flow	-180.05M	-230.18M	-171.76M	-129.89M	-32.83M	-48.11M	-15M	-2.28M